News
The one-shot vaccine, developed by Panacea Biotec and branded as DengiAll, is being tested through a multi-centre, ...
Newspoint on MSN10h
Phase-3 clinical trial enrolment for India’s first dengue vaccine to be completed by October: ICMREnrolment of about 10,500 participants in the phase III clinical trial of the indigenous one-shot Panacea Biotec developed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback